The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
With a potential treatment for Alzheimer’s disease, a deal to co-develop a proven-effective COVID-19 vaccine for the U.S. market, and a platform of red-blood-cell-based cancer… Read More »Contraindicated: Why These 3 Biotech Stocks With Massive Gains Could Be Toxic For Portfolios
With Their Pipelines And Upcoming Catalysts, These 3 Biotech Stocks Have The Potential To More Than Double
When it comes to biotech stocks, the author of today’s article notes that “An investment decision backed by careful scrutiny and analysis — of a company’s pipeline,… Read More »With Their Pipelines And Upcoming Catalysts, These 3 Biotech Stocks Have The Potential To More Than Double
Unless you’re a full-time trader who’s able to spend all day researching and developing stock screens, it’s not easy to find compelling biotech stocks, right?… Read More »An Easy Way For Anyone To Find Compelling Biotech Stocks
Expanding Its “Crown Jewel” Medication Into Dermatology Could Take This Biotech From Underperformer To Outperformer
The underperforming biotech featured in today’s article may be well positioned to become an outperformer. How? As the author explains, the company “may soon be… Read More »Expanding Its “Crown Jewel” Medication Into Dermatology Could Take This Biotech From Underperformer To Outperformer
Mathematician, billionaire hedge fund manager and quantitative trading genius Jim Simons, one of the greatest investors of all time, recently staked new positions in two… Read More »2 Compelling Biotech Picks From This Trading Genius
Regardless of whether the COVID-19 pandemic abates this year or not, the telehealth trend is expected to continue – and that could help one of… Read More »A Return To Normal Or More ‘New Normal’, 2 Healthcare Stocks That Could Soar This Year
With several smaller drug and biotech companies still to report fourth-quarter earnings, today’s article highlights four which are expected to deliver earnings surprises in their… Read More »4 Drug/Biotech Stocks Set To Deliver Earnings Surprises
Among the five new biotech stocks to watch highlighted in today’s article are plays that cross over into pet care, robotics, life sciences and psychedelic… Read More »From Pet Care To Psychedelics, 5 New Biotech Stocks To Watch – And More!